- Home
- CC vs TVTX Comparison
CC vs TVTX Comparison
Compare CC & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CC
- TVTX
- Stock Information
- Founded
- CC 2014
- TVTX 2008
- Country
- CC United States
- TVTX United States
- Employees
- CC N/A
- TVTX N/A
- Industry
- CC Major Chemicals
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- CC Industrials
- TVTX Health Care
- Exchange
- CC Nasdaq
- TVTX Nasdaq
- Market Cap
- CC 2.3B
- TVTX 2.5B
- IPO Year
- CC N/A
- TVTX N/A
- Fundamental
- Price
- CC $13.85
- TVTX $29.81
- Analyst Decision
- CC Buy
- TVTX Strong Buy
- Analyst Count
- CC 8
- TVTX 15
- Target Price
- CC $18.00
- TVTX $34.86
- AVG Volume (30 Days)
- CC 2.8M
- TVTX 1.7M
- Earning Date
- CC 11-06-2025
- TVTX 10-30-2025
- Dividend Yield
- CC 2.53%
- TVTX N/A
- EPS Growth
- CC N/A
- TVTX N/A
- EPS
- CC N/A
- TVTX N/A
- Revenue
- CC $5,850,000,000.00
- TVTX $333,865,000.00
- Revenue This Year
- CC $4.88
- TVTX $83.23
- Revenue Next Year
- CC $0.21
- TVTX $41.49
- P/E Ratio
- CC N/A
- TVTX N/A
- Revenue Growth
- CC 0.62
- TVTX 87.94
- 52 Week Low
- CC $9.13
- TVTX $12.91
- 52 Week High
- CC $22.38
- TVTX $30.97
- Technical
- Relative Strength Index (RSI)
- CC 44.69
- TVTX 76.08
- Support Level
- CC $12.69
- TVTX $26.79
- Resistance Level
- CC $14.27
- TVTX $28.24
- Average True Range (ATR)
- CC 0.74
- TVTX 1.07
- MACD
- CC 0.02
- TVTX 0.08
- Stochastic Oscillator
- CC 52.68
- TVTX 80.27
About CC Chemours Company (The)
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.